# DHA Proof-of-Concept Study in Infants and Toddlers

> **NCT05266677** · NA · WITHDRAWN · sponsor: **Société des Produits Nestlé (SPN)**

## Conditions studied

- Infants
- Toddlers
- Nutritional Supplement

## Interventions

- **OTHER:** blend of glycerides at certain proportions
- **OTHER:** glycerides used in current formulas

## Key facts

- **NCT ID:** NCT05266677
- **Lead sponsor:** Société des Produits Nestlé (SPN)
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-07
- **Primary completion:** 2023-03
- **Final completion:** 2023-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Foreseen high level of subject burden and non compliance in the clinical trial due to extensive product preparation and the nutritional concept for the improvement of RBC DHA is compromised by the change in the product formulation
- **Last updated:** 2022-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05266677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05266677, "DHA Proof-of-Concept Study in Infants and Toddlers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05266677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*